New cymbalta contraindication

Duloxetine has been associated with an increase in blood pressure and cases of hypertensive crisis have been reported, especially in patients with pre-existing hypertension.

Therefore, Cymbalta (duloxetine hydrochloride) is now contraindicated in patients with uncontrolled hypertension. For patients who experience a sustained increase in blood pressure while receiving duloxetine, either a dose reduction or gradual discontinuation should be considered. In patients with known hypertension and/or other cardiac disease, blood pressure monitoring is recommended, especially during the first month of treatment.

Further information: Lilly 01256 315000

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases